SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 214 filers reported holding SAGE THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.42 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $255,192 | -56.2% | 12,400 | 0.0% | 0.05% | -54.2% |
Q2 2023 | $583,048 | -46.6% | 12,400 | -52.3% | 0.11% | -37.4% |
Q1 2023 | $1,090,960 | +10.0% | 26,000 | 0.0% | 0.17% | +5.6% |
Q4 2022 | $991,640 | -2.6% | 26,000 | 0.0% | 0.16% | -8.0% |
Q3 2022 | $1,018,000 | +21.2% | 26,000 | 0.0% | 0.18% | +21.4% |
Q2 2022 | $840,000 | -2.4% | 26,000 | 0.0% | 0.14% | -13.2% |
Q1 2022 | $861,000 | -22.2% | 26,000 | 0.0% | 0.17% | -31.3% |
Q4 2021 | $1,106,000 | -66.5% | 26,000 | -65.1% | 0.24% | -66.6% |
Q3 2021 | $3,297,000 | -22.0% | 74,400 | 0.0% | 0.73% | -17.0% |
Q2 2021 | $4,227,000 | – | 74,400 | – | 0.88% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Integral Health Asset Management, LLC | 311,000 | $10,294,000 | 2.68% |
Palo Alto Investors LP | 851,719 | $28,192,000 | 2.18% |
Boxer Capital, LLC | 1,094,000 | $36,211,000 | 1.86% |
DAFNA Capital Management LLC | 180,306 | $5,968,000 | 1.56% |
Deep Track Capital, LP | 675,000 | $22,343,000 | 1.43% |
Bellevue Group AG | 3,052,404 | $101,034,000 | 1.17% |
Ikarian Capital, LLC | 249,907 | $8,272,000 | 1.09% |
Ikarian Capital, LLC | 250,000 | $8,275,000 | 1.09% |
Artal Group S.A. | 750,000 | $24,825,000 | 1.04% |
SECTOR GAMMA AS | 118,476 | $3,922,000 | 0.85% |